David Berd
Founder at BIOVAXYS TECHNOLOGY CORP.
Net worth: 279 780 $ as of 2024-03-30
Profile
David Berd was the Chief Medical Officer and founder of BioVaxys Technology Corp.
He was the Chief Medical Officer at AVAX Technologies, Inc. from 2004 to 2016.
He was also the National Director-Immunotherapy at Cancer Treatment Centers of America, Inc. He worked as a Professor at Thomas Jefferson University.
Dr. Berd earned his doctorate degree from Thomas Jefferson University Hospital in 1968 and his undergraduate degree from Pennsylvania State University College of Medicine in 1966.
Dr. Berd is also the founder of BioVaxys LLC.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOVAXYS TECHNOLOGY CORP
3.44% | 2022-08-01 | 4,996,067 ( 3.44% ) | 279 780 $ | 2024-03-30 |
David Berd active positions
| Companies | Position | Start |
|---|---|---|
| BIOVAXYS TECHNOLOGY CORP. | Founder | 2020-09-29 |
BioVaxys LLC
 BioVaxys LLC BiotechnologyHealth Technology BioVaxys LLC is a clinical stage biotechnology company, which engages in the development of immunotherapeutic vaccines for antiviral and individualized cancer therapy. It focuses on multihaptenized autologous vaccine that will initially be developed and marketed for melanoma and ovarian cancer. The company was founded by James Passin, Kenneth Kovan and David Berd and is headquartered in New York, NY. | Founder | - |
Former positions of David Berd
| Companies | Position | End |
|---|---|---|
| AVAX TECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 2016-07-31 |
Cancer Treatment Centers of America, Inc.
 Cancer Treatment Centers of America, Inc. Hospital/Nursing ManagementHealth Services Cancer Treatment Centers of America, Inc. operates cancer treatment hospitals. It offers surgical oncology, chemotherapy, radiation therapy, stem cell transplantation, and photodynamic therapy treatments. The firm provides treatments for bladder, colon, kidney, lung, ovarian, pancreatic, and skin cancer. The company was founded by Richard J. Stephenson in 1988 and is headquartered in Schaumburg, IL. | Corporate Officer/Principal | - |
| Thomas Jefferson University | Corporate Officer/Principal | - |
Training of David Berd
| Thomas Jefferson University Hospital | Doctorate Degree |
| Pennsylvania State University College of Medicine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AVAX TECHNOLOGIES, INC. | Health Technology |
| BIOVAXYS TECHNOLOGY CORP. | Non-Energy Minerals |
| Private companies | 2 |
|---|---|
Cancer Treatment Centers of America, Inc.
Cancer Treatment Centers of America, Inc. Hospital/Nursing ManagementHealth Services Cancer Treatment Centers of America, Inc. operates cancer treatment hospitals. It offers surgical oncology, chemotherapy, radiation therapy, stem cell transplantation, and photodynamic therapy treatments. The firm provides treatments for bladder, colon, kidney, lung, ovarian, pancreatic, and skin cancer. The company was founded by Richard J. Stephenson in 1988 and is headquartered in Schaumburg, IL. | Health Services |
BioVaxys LLC
BioVaxys LLC BiotechnologyHealth Technology BioVaxys LLC is a clinical stage biotechnology company, which engages in the development of immunotherapeutic vaccines for antiviral and individualized cancer therapy. It focuses on multihaptenized autologous vaccine that will initially be developed and marketed for melanoma and ovarian cancer. The company was founded by James Passin, Kenneth Kovan and David Berd and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- David Berd
